;[Ala26, Leu27]-Melan-A (26-35);ALAGIGILTV;;[Ala26]-Melan-A/MART-1 (26-35);AAAGIGILTV; CAS

吉尔生化(上海)有限公司 Company Information

Company Name:	GL Biochem (Shanghai) Ltd
Tel:	21-61263452
Email:	ymbetter@glbiochem.com
Nationality:	China
WebSite:	www.glschina.com/
Product List:	9981

74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100

Product List

[Ala26, Leu27]-Melan-A (26-35);ALAGIGILTV

[Ala26]-Melan-A/MART-1 (26-35);AAAGIGILTV

[Ala6,D-Trp8]-Galanin (1-15)-ol;GWTLNAAwYLLGPHA-ol

[Cys3,6, Tyr8, Pro9]-Substance P;RPCPQCFYPLM-NH2(Disulfidebridge:3-6)

141459-28-1

[D-Arg25]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALrHYINLITRQRY-NH2

[Deamino-Cys1, D-Arg8]-Vasopressin, free acid;3-Mercaptopropionyl-YFQNCPrG(Disulfidebridge:1-6)

[Des-Ac]-α-MSH, amide;SYSMEHFRWGKPV-NH2

[Des-Arg10]-HOE I40;rRP-Hyp-G-Thi-S-(D-Tic)-Oic

[D-His26]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALRhYINLITRQRY-NH2

[D-Trp34]-Neuropeptide Y, human;YPSKPDNPGEDAPAEDMARYYSALRHYINLITRwRY-NH2

[D-Trp6,8,9]-Galanin (1-15)-ol;GWTLNwAwwLLGPHA-ol

[D-Tyr11]-Neurotensin;Pyr-LYENKPRRPyIL

39379-15-2

[D-Tyr6, ?-Ala11, ?-Phe13, Nle14]-Bombesin (1-14);Pyr-QRLGyQWAV-(?-A)-H-(?-F)-Nle-NH2

[D-Tyr6, ?-Ala11, Phe13, Nle14]-Bombesin (6-14);yQWAV-(?-A)-HF-Nle-NH2

[Gln11]-beta-Amyloid (1-40);DAEFRHDSGYQVHHQKLVFFAEDVGSNKGAIIGLMVGGVV

106686-61-7

[Gln144]-PLP (139-151), Q144-PLP(139-151);HSLGKQLGHPDKF

[Gln22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV

[Gln22]-beta-Amyloid (6-40);HDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV

[Gly22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVV

[Gly30, Cys31] β-Amyloid (13-31)??NEW;HHQKLVFFAEDVGSNKGGC

[Ile34] Beta-Amyloid (25-34);GSNKGAIIGI

[Leu144]-PLP (139-151), L144-PLP(139-151);HSLGKLLGHPDKF

[Leu27]-Melan-A, MART 1 (26-35);ELAGIGILTV

[Leu28]-Melan-A (27-35);ALGIGILTV

[Lys0]-γ-1-MSH (41-58), amide;KYVMGHFRWDRFG-NH2

[Lys4]-Sarafotoxin 6c;CTCKDMTDEECLNFCHQDVIW(Disulfidebridge:1-15and3-11)

[Lys5, NMeLeu9, NIe10]-Neurokinin A (4-10);DKFVG-(NMeL)-NIe-NH2

[Nle35] beta-Amyloid (17-42);LVFFAEDVGSNKGAIIGL-Nle-VGGVVIA

[Nle35]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVV

[Nle35]-beta-Amyloid (1-42);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVVIA

[Nle35]-Beta-Amyloid (25-35);GSNKGAIIGL-Nle

163265-32-5

[pS119] CREB327 (113-126), Biotinyl??;Biotin-ILSRRP(pS)YRKILND

[pSer5]-Kemptide, 5-TMR labeled;5-TMR-LRRA-pS-LG

[pSer5]-Kemptide, Biotinylated, Amide;Biotin-LRRA-pS-LG-NH2

520 MMP FRET Substrate X;QXL?520-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-Lys(5-FAM)-NH2

520 MMP FRET Substrate VIII;QXL?520-RPKPLA-Nva-WK(5-FAM)-NH2

520 MMP FRET Substrate VII;QXL?520-PYAYWMRK(5-FAM)-NH2

520 MMP FRET Substrate VI;QXL?520-Pro-Leu-Gly-Met-Trp-Ser-Arg-Lys(5-FAM)-NH2

520 MMP FRET Substrate V;5-FAM-Pro-Leu-Gly-Leu-Dap(QXL?520)-Ala-Arg-NH2

520 MMP FRET Substrate IX;QXL?520-RPLALWRK(5-FAM)-NH2

520 MMP FRET Substrate IV;5-FAM-Pro-Leu-Ala-Nva-Dap(QXL?520)-Ala-Arg-NH2

520 MMP FRET Substrate III;QXL?520-Pro-Leu-Gly-Cys(Me)-His-Ala-Arg-Lys(5-FAM)-NH2

520 MMP FRET Substrate II;QXL?520-Pro-Leu-Ala-Leu-Trp-Ala-Arg-Lys(5-FAM)-NH2

[pSer5]-Kemptide, Biotinylated-LC;Biotin-LC-LRRA-pS-LG

[pSer5]-Kemptide, HiLyte Fluor? 488 labeled;HiLyteFluor?488-LRRA-pS-LG

[Pyr11]-beta-Amyloid (11-40);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVV

192377-94-9

[Pyr11]-beta-Amyloid (11-42);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA

[Pyr3]-beta-Amyloid (3-40);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV

[Pyr3]-beta-Amyloid (3-42);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA

183449-57-2

[Ser102]-MCC (88-103), MCC (T102S);ANERADLIAYLKQASK

[Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, human, rat;YSEEPPISLDLTFHLLREVLEEMARAEQLAQQAHSNRKLMEII-NH2

100513-58-4

[Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, ovine;YSQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA-NH2

[Tyr0]-α-Calcitonin Gene Related Peptide, [Tyr0]-α-CGRP, rat;YSCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2(Disulfidebridge:2-7)

[Tyr11] Head Activator;Pyr-PPGGSKVILY

[Tyr22]-α-CGRP (22-37), rat;YVKDNFVPTNVGSEAF-NH2

[Tyr8]-Atrial Natriuretic Peptide (5-27), [Tyr8]-Atriopeptin II, rat;SSCYGGRIDRIGAQSGLGCNSFR(Disulfidebridge:3-19)

Beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV

2837b, Hemoglobin Fragment, Plasmepsin II (PM II) substrate, EDANS/ DABCYL??;EDANS-CO-CH2-CH2-CO-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-Dap(DABCYL)-OH

390 MMP FRET Substrate II;Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-OH

490 MMP FRET Substrate III;DABCYL-RPLALWRS-EDANS

490 MMP FRET Substrate IV;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Asp(EDANS)-Ala-Arg-NH2

490 MMP FRET Substrate V;NBD-RPKPLA-Nva-WK(DMC)-NH2

490 MMP FRET Substrate VI;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Dap(AMCA)-Ala-Arg-NH2

490 MMP FRET Substrate VII;Dabcyl-Lys-Pro-Leu-Ala-Nva-Dap(AMCA-X)-NH2

4A/4B Peptide (3), EDANS-labeled;DEMEECASHLPY-E(EDANS)-NH2

520 MMP FRET Substrate I;QXL520?-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-Lys(5-FAM)-NH2

5A, pNA-labeled;EDVV-Abu-C-pNA

580 MMP FRET Substrate I;QXL?570-Lys-Pro-Leu-Ala-Nva-Dap(5-TAMRA)-Ala-Arg-NH2

520 MMP FRET Substrate XVII;QXL?520-Lys-Pro-Leu-Ala-Nva-Dap(5-FAM)-Ala-Arg-NH2

520 MMP FRET Substrate XVI;QXL?520-RPKPQQFWK(5-FAM)-NH2

520 MMP FRET Substrate XV;QXL?520-γ-Abu-Pro-Gln-Gly-Leu-Dab(5-FAM)-Ala-Lys-NH2

520 MMP FRET Substrate XIV;QXL?520-γ-Abu-Pro-Cha-Abu-Smc-His-Ala-Dab(5-FAM)-Ala-Lys-NH2(Smc=S-Methyl-L-cysteine)

520 MMP FRET Substrate XIII;5-FAM-RPKPVE-Nva-WRK(QXL?520)-NH2

520 MMP FRET Substrate XII;5-FAM-RPKPYA-Nva-WM-K(QXL?520)-NH2

520 MMP FRET Substrate XI;5-FAM-Pro-Cha-Gly-Nva-His-Ala-Dap(QXL?520)-NH2

β-Secretase Substrate I, Fluorogenic

δ1-MSH, amide

72629-65-3

γ-2-MSH (41-58), amide;YVMGHFRWDRFG-NH2

γ-TAC4 (30-61)-NH2??;TEAETWEGAGPSIQLQLQEVKTGKASQFFGLM-NH2

δ-Endorphin (bovine, camel, mouse, ovine)

(Arg)9, FAM-labeled;FAM-RRRRRRRRR

(Arg)9, TAMRA-labeled;TAMRA-RRRRRRRRR

(pS8, pS13) Eucariotic Translation Initiation Factor 2B, eIF2B??;RRAAEELDpSRAGpSPQL

(Z-AR)2Rh110?2HCl;(Z-AR)2Rh110?HCl

(Z-Arg)2Rh110 ? 2HCl;(Z-R)2Rh110?2HCl

(Z-Phe-Arg)2Rh110;(Z-FR)2Rh110

?-Bag Cell Peptide;RLRFH

?-Neuroprotectin;aDLIAYL-NH2

[3,4-Dehydro-Pro]3-Thyrotropin Releasing Hormone, [ΔPro3]-TRH

4A/4B Peptide (2);DEMEECASHLPY-K(Ac)-NH2

[4-Chloro-Phe]7,8-Substance P;RPKPQQ-F(4-Cl-F)-GLM-NH2

73646-81-8

[Ala144]-PLP (139-151) A144-PLP(139-151);HSLGKALGHPDKF

β-Endorphin, equine

74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100